Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14611-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14611-1-AP, RRID:AB_2201447
- Product name
- MYO18A antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated MYO18A antibody (Cat. #14611-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma.
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.
Unbiased Profiling of the Human Proinsulin Biosynthetic Interaction Network Reveals a Role for Peroxiredoxin 4 in Proinsulin Folding.
Pushing myelination - developmental regulation of myosin expression drives oligodendrocyte morphological differentiation.
A novel isoform of myosin 18A (Myo18Aγ) is an essential sarcomeric protein in mouse heart.
A Portrait of the Human Organelle Proteome In Space and Time during Cytomegalovirus Infection.
Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.
GM-CSF modulates pulmonary resistance to influenza A infection.
Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.
Tan X, Shi L, Banerjee P, Liu X, Guo HF, Yu J, Bota-Rabassedas N, Rodriguez BL, Gibbons DL, Russell WK, Creighton CJ, Kurie JM
The Journal of clinical investigation 2021 Jan 4;131(1)
The Journal of clinical investigation 2021 Jan 4;131(1)
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.
Uzureau S, Lecordier L, Uzureau P, Hennig D, Graversen JH, Homblé F, Mfutu PE, Oliveira Arcolino F, Ramos AR, La Rovere RM, Luyten T, Vermeersch M, Tebabi P, Dieu M, Cuypers B, Deborggraeve S, Rabant M, Legendre C, Moestrup SK, Levtchenko E, Bultynck G, Erneux C, Pérez-Morga D, Pays E
Cell reports 2020 Mar 17;30(11):3821-3836.e13
Cell reports 2020 Mar 17;30(11):3821-3836.e13
Unbiased Profiling of the Human Proinsulin Biosynthetic Interaction Network Reveals a Role for Peroxiredoxin 4 in Proinsulin Folding.
Tran DT, Pottekat A, Mir SA, Loguercio S, Jang I, Campos AR, Scully KM, Lahmy R, Liu M, Arvan P, Balch WE, Kaufman RJ, Itkin-Ansari P
Diabetes 2020 Aug;69(8):1723-1734
Diabetes 2020 Aug;69(8):1723-1734
Pushing myelination - developmental regulation of myosin expression drives oligodendrocyte morphological differentiation.
Domingues HS, Urbanski MM, Macedo-Ribeiro S, Almaktari A, Irfan A, Hernandez Y, Wang H, Relvas JB, Rubinstein B, Melendez-Vasquez CV, Pinto IM
Journal of cell science 2020 Aug 5;133(15)
Journal of cell science 2020 Aug 5;133(15)
A novel isoform of myosin 18A (Myo18Aγ) is an essential sarcomeric protein in mouse heart.
Horsthemke M, Nutter LMJ, Bachg AC, Skryabin BV, Honnert U, Zobel T, Bogdan S, Stoll M, Seidl MD, Müller FU, Ravens U, Unger A, Linke WA, van Gorp PRR, de Vries AAF, Bähler M, Hanley PJ
The Journal of biological chemistry 2019 May 3;294(18):7202-7218
The Journal of biological chemistry 2019 May 3;294(18):7202-7218
A Portrait of the Human Organelle Proteome In Space and Time during Cytomegalovirus Infection.
Jean Beltran PM, Mathias RA, Cristea IM
Cell systems 2016 Oct 26;3(4):361-373.e6
Cell systems 2016 Oct 26;3(4):361-373.e6
Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.
De Masson A, Giustiniani J, Marie-Cardine A, Bouaziz JD, Dulphy N, Gossot D, Validire P, Tazi A, Garbar C, Bagot M, Merrouche Y, Bensussan A
Oncoimmunology 2016 May;5(5):e1127493
Oncoimmunology 2016 May;5(5):e1127493
GM-CSF modulates pulmonary resistance to influenza A infection.
Sever-Chroneos Z, Murthy A, Davis J, Florence JM, Kurdowska A, Krupa A, Tichelaar JW, White MR, Hartshorn KL, Kobzik L, Whitsett JA, Chroneos ZC
Antiviral research 2011 Nov;92(2):319-28
Antiviral research 2011 Nov;92(2):319-28
Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.
Sever-Chroneos Z, Krupa A, Davis J, Hasan M, Yang CH, Szeliga J, Herrmann M, Hussain M, Geisbrecht BV, Kobzik L, Chroneos ZC
The Journal of biological chemistry 2011 Feb 11;286(6):4854-70
The Journal of biological chemistry 2011 Feb 11;286(6):4854-70
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 14611-1-AP(MYO18A antibody) at dilution of 1:6000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MYO18A antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MYO18A. This antibody recognizes human,mouse,rat antigen. The MYO18A antibody has been validated for the following applications: ELISA, WB, IP analysis.